COMPOUND (INN): HOE490O - GLIMEPIRIDE / METFORMIN HCl (Amaryl® M)0 (Glimepiride/Metformin Hydrochloride Immediate Release Combination Tablet) in Fed Conditions in Healthy Male and/or Female Subjects.

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

December 31, 2015

Conditions

Healthy

Interventions

DRUG

: Amaryl® M IR 2/1000

Trial Locations (1)

Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit, Amman